Homo sapiens Protein: PEX5
Summary
InnateDB Protein IDBP-16153.7
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol PEX5
Protein Name peroxisomal biogenesis factor 5
Synonyms PBD2A; PBD2B; PTS1-BP; PTS1R; PXR1;
Species Homo sapiens
Ensembl Protein ENSP00000266564
InnateDB Gene IDBG-16151 (PEX5)
Protein Structure
UniProt Annotation
Function Binds to the C-terminal PTS1-type tripeptide peroxisomal targeting signal (SKL-type) and plays an essential role in peroxisomal protein import. {ECO:0000269PubMed:7706321, ECO:0000269PubMed:7719337, ECO:0000269PubMed:7790377}.
Subcellular Localization Cytoplasm. Peroxisome membrane; Peripheral membrane protein. Note=Its distribution appears to be dynamic. It is probably a cycling receptor found mainly in the cytoplasm and as well associated to the peroxisomal membrane through a docking factor (PEX13).
Disease Associations Peroxisome biogenesis disorder 2A (PBD2A) [MIM:214110]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and characterized clinically by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. {ECO:0000269PubMed:7719337}. Note=The disease is caused by mutations affecting the gene represented in this entry.Peroxisome biogenesis disorder 2B (PBD2B) [MIM:202370]: A peroxisome biogenesis disorder that includes neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), two milder manifestations of the Zellweger disease spectrum. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy and vision impairment. Children with the NALD presentation may reach their teens, while patients with the IRD presentation may reach adulthood. The clinical conditions are often slowly progressive in particular with respect to loss of hearing and vision. The biochemical abnormalities include accumulation of phytanic acid, very long chain fatty acids (VLCFA), di- and trihydroxycholestanoic acid and pipecolic acid. {ECO:0000269PubMed:10462504, ECO:0000269PubMed:7719337}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity Detected in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269PubMed:7706321, ECO:0000269PubMed:7719337, ECO:0000269PubMed:7790377}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 92 experimentally validated interaction(s) in this database.
Experimentally validated
Total 92 [view]
Protein-Protein 92 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0000268 peroxisome targeting sequence binding
GO:0005052 peroxisome matrix targeting signal-1 binding
GO:0005515 protein binding
GO:0008022 protein C-terminus binding
GO:0019899 enzyme binding
GO:0031267 small GTPase binding
GO:0047485 protein N-terminus binding
Biological Process
GO:0006625 protein targeting to peroxisome
GO:0016558 protein import into peroxisome matrix
GO:0016560 protein import into peroxisome matrix, docking
GO:0016561 protein import into peroxisome matrix, translocation
GO:0045046 protein import into peroxisome membrane
GO:0051262 protein tetramerization
GO:1901094 negative regulation of protein homotetramerization
Cellular Component
GO:0005622 intracellular
GO:0005737 cytoplasm
GO:0005777 peroxisome
GO:0005778 peroxisomal membrane
GO:0005782 peroxisomal matrix
GO:0005794 Golgi apparatus
GO:0005829 cytosol
GO:0016020 membrane
GO:0043234 protein complex
Protein Structure and Domains
PDB ID
InterPro IPR001440 Tetratricopeptide TPR1
IPR013026 Tetratricopeptide repeat-containing domain
IPR019734 Tetratricopeptide repeat
PFAM PF00515
PF13174
PF13176
PF13181
PRINTS
PIRSF
SMART SM00028
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P50542
PhosphoSite PhosphoSite-P50542
TrEMBL F5H432
UniProt Splice Variant
Entrez Gene 5830
UniGene Hs.567327
RefSeq NP_000310
HUGO HGNC:9719
OMIM 600414
CCDS CCDS8576
HPRD 02684
IMGT
EMBL AC018653 AK292256 AK302742 AK316250 BC010621 CH471116 U19721 X84899 Z48054
GenPept AAC50103 AAH10621 BAF84945 BAG63957 BAH14621 CAA59324 CAA88131 EAW88671 EAW88672 EAW88674